Skip to Content

245 (Imatinib Mesylate 400 mg)

Pill with imprint 245 is Yellow, Elliptical / Oval and has been identified as Imatinib Mesylate 400 mg. It is supplied by Zydus Pharmaceuticals (USA) Inc..

Imatinib is used in the treatment of chronic myelogenous leukemia; dermatofibrosarcoma protuberans; acute lymphoblastic leukemia; chronic eosinophilic leukemia; gastrointestinal stromal tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 245

Imatinib mesylate 400 mg 245

Imatinib Mesylate

Imprint
245
Strength
400 mg
Color
Yellow
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Bcr-abl tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Zydus Pharmaceuticals (USA) Inc.
Manufacturer
Cadila Healthcare Limited
National Drug Code (NDC)
70771-1395

Get help with Imprint Code FAQs.

Related Images for "245"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.